SGRY
Surgery Partners Inc.
$21.62
-$0.41(-1.86%)
48
Overall
--
Value
40
Tech
57
Quality
Market Cap
$2.77B
Volume
1.81M
52W Range
$18.87 - $33.37
Target Price
$30.82
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $959.9M | $1.1B | $592.6M | $1.8B | $1.8B | $1.9B | $2.2B | $2.5B | $2.7B | $3.1B | ||
| Total Revenue | $959.9M | $1.1B | $592.6M | $1.8B | $1.8B | $1.9B | $2.2B | $2.5B | $2.7B | $3.1B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-669.3M | $-821.2M | $-441.6M | $-1.4B | $1.4B | $1.5B | $1.7B | $2.0B | $2.1B | $2.4B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $959.9M | $1.1B | $441.6M | $-31.8M | $1.8B | $379.8M | $491.4M | $574.9M | $2.7B | $3.1B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-815.1M | $-949.0M | $504.9M | $-1.7B | $1.6B | $1.7B | $1.9B | $214.6M | $2.4B | $2.8B | ||
| Research & Development | -- | -- | $26.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Research Expense | -- | -- | $26.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling, General & Administrative | $409.5M | $462.8M | $263.1M | $816.1M | $787.0M | $826.9M | $970.4M | $1.1B | $1.2B | $1.3B | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | $543.6M | $538.4M | $636.4M | $709.7M | $745.0M | $812.9M | ||
| General & Administrative Expenses | $409.5M | $462.8M | $263.1M | $816.1M | $243.4M | $288.5M | $334.0M | $371.4M | $417.7M | $495.8M | ||
| Salaries & Wages | $261.7M | $357.2M | $175.4M | $534.7M | $550.0M | $550.3M | $644.3M | $746.4M | $793.8M | $907.5M | ||
| Depreciation & Amortization | $34.5M | $39.6M | $21.8M | $67.4M | $76.5M | $94.8M | $98.8M | $114.8M | $118.1M | $152.6M | ||
| Depreciation & Amortization | $34.5M | $39.6M | $21.8M | $67.4M | $76.5M | $94.8M | $98.8M | $114.8M | $118.1M | $152.6M | ||
| Amortization | $-9.1M | $-9.6M | $-1.8M | $-4.9M | $3.4B | $3.5B | $3.9B | $4.2B | $2.9M | $46.9M | ||
| Other Operating Expenses | $81.8M | $85.3M | $44.6M | $104.2M | $28.1M | $65.9M | $77.5M | $156.7M | $175.3M | $201.7M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $172.4M | $200.6M | $-504.9M | $-1.6B | $235.9M | $183.0M | $302.2M | $345.2M | $328.0M | $348.8M | ||
| EBITDA | $84.2M | $142.2M | $40.4M | $-1.8M | $273.2M | $277.8M | $401.0M | $460.0M | $301.7M | $361.5M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $13.0M | $201.8M | $221.0M | $234.9M | $48.6M | $61.8M | ||
| Intinc | $-101.0M | $-100.6M | $-48.7M | $-147.0M | $-178.9M | $-201.8M | $-221.0M | $-234.9M | $-193.0M | $-201.7M | ||
| Net Non-Operating Interest Income/Expense | $-101.0M | $-100.6M | $-48.7M | $-147.0M | $-178.9M | $-201.8M | $-221.0M | $-234.9M | $-193.0M | $-201.7M | ||
| Gain on Sale of Securities | -- | -- | -- | $1.1M | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $28.1M | $18.2M | $-589.6M | $-1.7B | $20.5M | $12.4M | $37.6M | $-15.1M | $63.0M | $85.7M | ||
| Other Special Charges | $-16.1M | $-11.9M | $592.6M | $1.8B | $-11.7M | -- | $-9.1M | $-14.9M | $-15.5M | $-5.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $525.0K | $14.0M | $8.7M | $-116.7M | $-6.7M | $-72.5M | $15.5M | $45.9M | $-3.1M | $20.8M | ||
| Impairment of Capital Assets | -- | -- | -- | $74.4M | $7.9M | $33.5M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $43.8M | $95.9M | $18.6M | $-69.2M | $196.7M | $183.0M | $302.2M | $345.2M | $183.6M | $208.9M | ||
| Pre-Tax Income | $43.8M | $95.9M | $18.6M | $-69.2M | $183.7M | $35.5M | $180.7M | $110.3M | $234.3M | $147.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-29.1M | $10.8M | $46.3M | $26.4M | $11.9M | $-20.1M | $10.5M | $23.3M | $-300.0K | $134.6M | ||
| NET INCOME | ||||||||||||
| Net Income | $1.4M | $9.5M | $-67.4M | $-238.1M | $-74.8M | $-116.1M | $-70.9M | $-54.6M | $-11.9M | $-168.1M | ||
| Net Income (Continuing Operations) | $1.4M | $9.5M | $-67.4M | $-238.1M | $-74.8M | $-116.1M | $-70.9M | $87.0M | $135.3M | $12.5M | ||
| Net Income (Discontinued Operations) | $1.4M | $9.5M | $-67.4M | $-238.1M | $-74.8M | $-116.1M | $-70.9M | $-54.6M | $-11.9M | $-168.1M | ||
| Net Income (Common Stockholders) | $1.4M | $9.5M | $-67.4M | $-238.1M | $-110.5M | $-155.6M | $-81.2M | $-54.6M | $-11.9M | $-168.1M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $353.7M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-1.5B | $-1.8B | $63.3M | $-3.1B | $1.6B | $1.7B | $1.9B | $2.2B | $2.4B | $2.8B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $36.1M | $48.0M | $48.3M | $48.0M | $48.3M | $48.8M | $72.4M | $92.0M | $125.6M | $126.1M | ||
| Average Shares Outstanding (Diluted) | $37.5M | $48.2M | $48.3M | $48.0M | $48.3M | -- | $72.4M | $92.0M | $125.6M | $126.1M | ||
| Shares Outstanding | $48.2M | $48.6M | $48.6M | $48.8M | $49.3M | $59.9M | $89.4M | $126.0M | $126.6M | $127.6M | ||
| Basic EPS | $0.04 | $0.20 | $-1.39 | $-3.25 | $-2.29 | $-3.19 | $-1.12 | $-0.59 | $-0.09 | $-1.33 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-2.29 | $-3.19 | $-1.12 | $-0.59 | $-0.09 | $-1.33 | ||
| Diluted EPS | $0.04 | $0.20 | $-1.39 | $-4.96 | $-2.29 | $-3.19 | $-1.12 | $-0.59 | $-0.09 | $-1.33 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-1.12 | $-0.59 | $-0.09 | $-1.33 | ||
| OTHER METRICS | ||||||||||||
| Accretion On Preferred Stock | -- | -- | $-32.4M | $-32.4M | -- | -- | $439.7M | -- | -- | -- | ||
| Accrued Preferred Stock Dividends | -- | -- | $-9.2M | $-33.8M | $-69.5M | $-39.5M | $-10.3M | -- | -- | -- | ||
| Acquisition Expense | -- | -- | -- | -- | $2.8M | $6.6M | $6.3M | $1.1M | $3.2M | -- | ||
| Earnings from equity interest | $3.8M | $4.8M | $3.3M | $8.9M | $10.2M | $10.8M | $11.3M | $12.5M | $14.2M | $19.5M | ||
| Earnings From Equity Interest Net Of Tax | $3.8M | $4.8M | $3.3M | $8.9M | $10.2M | $10.8M | $11.3M | $12.5M | $14.2M | $19.5M | ||
| Gain On Sale Of Business | -- | -- | $800.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $2.1M | $-2.4M | $-5.0K | $-31.8M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | $1.9M | -- | -- | -- | -- | -- | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | -- | -- | $26.0M | -- | -- | -- | $10.3M | -- | -- | -- | ||
| Minority Interests | $-71.4M | $-75.6M | $-39.6M | $-110.1M | $-119.9M | $-117.4M | $-141.6M | $-141.6M | $-147.2M | $-180.6M | ||
| Non Recurring Operation Expense | $-525.0K | $-14.0M | $-8.7M | $42.3M | $-1.2M | $39.0M | $-15.5M | $-45.9M | $3.1M | $-20.8M | ||
| Other Gand A | $409.5M | $462.8M | $263.1M | $816.1M | $243.4M | $288.5M | $334.0M | $371.4M | $417.7M | $495.8M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $-74.4M | $2.5M | $33.5M | -- | -- | -- | -- | ||
| Other Write Down | -- | -- | -- | -- | $35.7M | -- | -- | -- | -- | -- | ||
| Other Write Off | $-10.6M | $-12.7M | $-10.4M | -- | -- | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | -- | -- | $-32.4M | $-66.2M | $-69.5M | $-39.5M | $429.4M | -- | -- | -- | ||
| Preferred Stock Dividends | -- | -- | $-32.4M | $-66.2M | $-69.5M | $-39.5M | $429.4M | -- | -- | -- | ||
| Realized Capital Gain | -- | -- | $1.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $100.8M | $112.4M | $57.0M | $180.3M | $85.6M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | -- | -- | $35.7M | -- | -- | -- | -- | -- | ||
| Write Down | $-8.4M | $-552.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGRY | $21.62 | -1.9% | 1.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |